UFP Technologies Aims for 12%-18% Annual Growth Amid Medical Device M&A Opportunities
UFP Technologies (NASDAQ:UFPT) is targeting annual revenue growth of 12% to 18%, driven by both organic expansion and strategic acquisitions. The company, a contract development and manufacturing organization serving the medical-device industry, plans to evaluate five to ten potential acquisition targets with EBITDA ranging from $5 million to $30 million. These deals are intended to expand its customer base, technology portfolio, market segments, and geographic footprint. The CEO highlighted UFP's focus on a fragmented outsourcing segment within the global medical-device industry—estimated at around $100 billion in outsourced services—and noted that UFP holds less than 1% of this growing market. The company benefits from long-term customer relationships due to regulatory barriers and high switching costs, with typical product programs lasting over ten years. UFP reported approximately $600 million in revenue last year and operates across multiple countries including the US, Puerto Rico, Ireland, Mexico, Costa Rica, and the Dominican Republic. It serves a wide range of medical segments such as robotic-assisted surgery, orthopedics, wound care, infection control, and more.
Tickers: $UFPT
Topics: acquisition strategy contract manufacturing growth targets medical devices